Similar articles

• Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.

  Graña-Barcia M, Liz-Lestón J, Lado-Abeal J. Graña-Barcia M, et al. Fertil Steril. 2005 May;83(5):1466-72. doi: 10.1016/j.fertnstert.2004.11.046. Fertil Steril. 2005. PMID: 15866586
• [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].

  Vulkov I. Vulkov I. Akush Ginekol (Sofiia). 1976;15(6):459-62. Akush Ginekol (Sofiia). 1976. PMID: 797267 Bulgarian. No abstract available.
• Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.

  Yoshino K, Takahashi K, Nishigaki A, Eda Y, Kitao M. Yoshino K, et al. Int J Fertil. 1992 Mar-Apr;37(2):111-4. Int J Fertil. 1992. PMID: 1349592
• The effects of buserelin on the hormonal states in PCOD.

  Willemsen WN, Franssen AM, Rolland R, Vemer HM. Willemsen WN, et al. Prog Clin Biol Res. 1986;225:377-89. Prog Clin Biol Res. 1986. PMID: 3097673 Review. No abstract available.
• [Pathophysiology and diagnosis of polycystic ovary syndrome].

  Bouchard P. Bouchard P. J Gynecol Obstet Biol Reprod (Paris). 2003;32(3 Pt 2):S5-10. J Gynecol Obstet Biol Reprod (Paris). 2003. PMID: 12773912 Review. French. No abstract available.